跳至主要内容
临床试验/NL-OMON46907
NL-OMON46907已完成3 期

The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BMMNC) on all causemortality in acute myocardial infarction - BAMI

Queen Mary and Westfield College0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Signed and dated informed consent
  • 2. Men and women of any ethnic origin aged >= 18 years
  • 3. Patients with acute STelevation (including new LBBB)
  • myocardial infarction as defined by the universal definition of AMI.
  • 4. Successful acute reperfusion therapy (residual stenosis visually <50% and TIMI flow >=2) within 24 hours of symptom
  • onset or thrombolysis within 12 hours of symptom onset followed by successful percutaneous coronary intervention
  • (PCI) within 24 hours after thrombolysis
  • 5. Left ventricular ejection fraction <= 45% with significant regional wall motion abnormality assessed by quantitative
  • echocardiography (central, independent core lab analysis) 3 to 6 days after reperfusion therapy
  • 6. Open coronary artery suitable for cell infusion supplying the target area of abnormal wall motion

排除标准

  • 1. Participation in another clinical trial within 30 days prior to randomisation
  • 2. Previously received stem/progenitor cell therapy
  • 3. Pregnant or nursing women
  • 4. Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study or to follow the protocol
  • 5. Necessity to revascularise additional vessels, outside the target coronary artery at the time of BMMNC infusion (additional revascularisations after primary PCI and before BMMNC cell infusion are allowed), unless clinically indicated and according to latest guidelines. This decision should be madfe at the time of the index procedure and explicitly stated at the time.
  • 6. Cardiogenic shock requiring mechanical support
  • 7. Platelet count <100,000/µl, or hemoglobin <8.5 g/dl
  • 8. Impaired renal function, i.e. serum creatinine >2.5 mg/dl
  • 9. Persistent fever or diarrhea not responsive to treatment within 4 weeks prior screening
  • 10. Clinically significant bleeding within 3 months prior screening
  • 11. Uncontrolled hypertension (systolic >180 mmHg and diastolic >120 mmHg)
  • 12. Life expectancy of less than 2 years from any noncardiac
  • cause or neoplastic disease

研究者

发起方
Queen Mary and Westfield College

相似试验

进行中(未招募)
1 期
The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BMMNC) on all causemortality in acute myocardial infarction - BAMIMyocardial Infarction with reduced Left Ventricular ejection fractionMedDRA version: 14.1Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2012-001495-11-ITQueen Mary University London375
进行中(未招募)
1 期
A randomised trial to see if injecting patients' own bone marrow derived stem cells through their coronary artery changes mortality rate in patients after suffering from a heart attackMyocardial Infarction with reduced Left Ventricular ejection fractionMedDRA version: 18.0 Level: PT Classification code 10000891 Term: Acute myocardial infarction System Organ Class: 10007541 - Cardiac disorders
EUCTR2012-001495-11-FIQueen Mary University London3,000
进行中(未招募)
1 期
A rondomised trial to see if injecting patients' own bone marrow derived stem cells through their coronary artery changes mortality rate in patients after suffering from a heart attackMyocardial Infarction with reduced Left Ventricular ejection fraction
EUCTR2012-001495-11-BEQueen Mary University London375
进行中(未招募)
1 期
A randomised trial to see if injecting patients' own bone marrow derived stem cells through their coronary artery changes mortality rate in patients after suffering from a heart attackMyocardial Infarction with reduced Left Ventricular ejection fractionMedDRA version: 18.1Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2012-001495-11-CZQueen Mary University London375
进行中(未招募)
不适用
A randomised trial to see if injecting patients' own bone marrow derived stem cells through their coronary artery changes mortality rate in patients after suffering from a heart attack
EUCTR2012-001495-11-DEQueen Mary University London3,000
The effect of intracoronary reinfusion of bone... | 临床试验